Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

4.530 -0.010 (-0.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 799,419
Open 4.550
Bid (Size) 4.480 (2)
Ask (Size) 4.650 (2)
Prev. Close 4.540
Today's Range 4.351 - 4.590
52wk Range 4.000 - 12.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
Don't jump in without doing some research first. 
Via The Motley Fool
Compass Pathways to Participate in December Investor Conferences
From Compass Pathways plc
Via Business Wire

Performance

YTD
-49.61%
-49.61%
1 Month
-14.69%
-14.69%
3 Month
-33.87%
-33.87%
6 Month
-33.77%
-33.77%
1 Year
-41.17%
-41.17%

More News

Read More
COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
Via Benzinga
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
Via Benzinga
Uncovering Potential: Compass Pathways's Earnings Preview
Via Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Via Investor's Business Daily
Topics Government
Exposures Political
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Via Benzinga
Exposures Product Safety
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 3 Health Care Stocks You'll Regret Missing In November
Via Benzinga
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
Via Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
Via Benzinga
Exposures Fossil Fuels
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
From Compass Pathways plc
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
From Compass Pathways plc
Via Business Wire
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
Via Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
Via Benzinga
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
From Compass Pathfinder Limited
Via Business Wire
Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
Via Talk Markets
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Via Benzinga
Exposures Product Safety
Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.